Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Vemlidy (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

Drug (Brand / Generic)

Vemlidy (Tenofovir Alafenamide)

Current Indication

Hepatitis B

Market Sector

Anti-infective

Developer

Gilead Sciences

Development Status

Approved in the US
Expand

Go Top